RxDoctor Payments Data

Arlene Vazquez Young

Optometrist · Northport, NYNPI 1508932179

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,022 of the $3,451 with a category attached, or 87.6%. It is spread thinly across 11 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,411, 2.1 times the $660 reported in 2019.

$3,451in general payments, 2019–2025

Across 67 payments — averaging $51.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$802
  • Alcon$612
  • Visioneering Technologies, Inc.$587
  • Johnson & Johnson Vision Care, Inc.$527
  • Oyster Point Pharma, Inc.$264
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$249
  • plus $410 from 5 others

What the payments were for

  • Consulting fees$41112%
  • Food & beverage$3,02288%
  • Gifts$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,451 in reported general payments places this provider in the 85th percentile of 2,743 optometrist providers in New York.

See all optometrist providers in New York →

Medicare billing

Part B allowed, 2024
$19,002
Medicare patients
84
Services billed
396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone11$410

Paid to pharmacies, not to this prescriber.

Other optometrist in Northport

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →